Symbol Lookup from Yahoo Finance

Trending Tickers

Symbol	Name	Last Price	Change	Change %
RIVN	Rivian Automotive, Inc.	11.60	+1.36	+13.28%
ZENA	ZenaTech, Inc.	6.42	+4.63	+258.66%
BBY	Best Buy Co., Inc.	93.03	+3.49	+3.90%
LLY	Eli Lilly and Company	755.00	+6.99	+0.93%
KSS	Kohl's Corporation	18.34	+1.31	+7.69%
ZM	Zoom Video Communications, Inc.	89.03	+3.15	+3.67%
PSTX	Poseida Therapeutics, Inc.	2.8600	+0.1300	+4.76%
ANF	Abercrombie & Fitch Company	154.50	+2.51	+1.65%
DKS	Dick's Sporting Goods Inc	215.23	+5.07	+2.41%
BTC-USD	Bitcoin USD	92,318.18	-4,988.62	-5.13%
AMGN	Amgen Inc.	294.00	-0.53	-0.18%
ADI	Analog Devices, Inc.	223.58	+8.99	+4.19%
IDAI	T Stamp Inc.	0.1800	+0.0045	+2.56%
MDAI	Spectral AI, Inc.	1.3100	+0.1200	+10.08%
HIMS	Hims & Hers Health, Inc.	31.35	+6.02	+23.77%
SJM	The J.M. Smucker Company	113.62	+0.32	+0.28%
VKTX	Viking Therapeutics, Inc.	51.99	-0.60	-1.14%
NVO	Novo Nordisk A/S	104.56	-0.50	-0.48%
SMTC	Semtech Corporation	53.44	+2.55	+5.01%
ARWR	Arrowhead Pharmaceuticals, Inc.	18.79	+0.25	+1.35%
CTXR	Citius Pharmaceuticals, Inc.	3.3375	+3.2037	+2,394.39%
VSEE	VSee Health, Inc.	1.7200	+0.2400	+16.22%
INTC	Intel Corporation	24.87	+0.37	+1.51%
CADUSD=X	USD/CAD	1.4118	+0.0133	+0.95%
SAVA	Cassava Sciences, Inc.	4.2950	-22.1850	-83.78%

Related News

New Trump tariffs, Fed minutes, Intel CHIPS grant: 3 Things

President-elect Donald Trump has threatened to levy import tariffs against China, Mexico, and Canada. Stock futures (ES=F, NQ=F, YM=F) appear mixed this morning on the headline, while shares Big Three automakers Ford (F), Stellantis (STLA), and General Motors (GM) move into negative territory in pre-market trading. Wall Street will be listening for the Federal Reserve to release the minutes from its November FOMC meeting, looking for any hints into the central bank's sentiments around its interest rate path ahead of its December meeting. According to Bloomberg, Intel (INTC) is set to receive $7.9 billion in CHIPS Act grants from the US government, while the chipmaker's interest in acquiring Qualcomm (QCOM) has cooled. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 4 minutes ago

F

STLA
Should the US Treasury be buying bitcoin?

With Wyoming Senator Cynthia Lummis advocating for the US Treasury to create a bitcoin (BTC-USD) reserve, many are debating the merits of the department investing in cryptocurrency. On this week’s episode of Capitol Gains, Whalen Global Advisors Chairman Chris Whalen offers his take on the matter to host Rachelle Akuffo, Washington Correspondent Ben Werschkul, and senior columnist Rick Newman. “We're in the opposite situation that Franklin Roosevelt faced in 1933,” he explains. “We had deflation [in 1933]. Today we have inflation. That's why bitcoin has hit $100,000. Bitcoin is the best indication of inflation you could possibly have.” To Whalen, the answer lies not in crypto, but in gold. He believes the solution is for the Treasury to buy gold (GC=F) and sell credit default swaps. “You buy gold and start pushing the gold price up to where it should be,” he explains, “which is much higher than the current levels.” “Credit default swaps for the United States are trading at 40 basis points,” he adds. “That's twice Berkshire Hathaway. (BRK-B, BRK-A) When you start seeing corporates trading inside the United States in the credit markets, that's a problem. I think ultimately, we are going to have to respond to that.” “Unfortunately, nobody on Capitol Hill understands finance,” Whalen says. “Bitcoin is the problem. It's not the solution.” To find out more, listen to the full episode of Capitol Gains here. For more expert insight and the latest market action, click here to watch more Capitol Gains. This post was written by Nick Riccardo.

Yahoo Finance Video 1 hour ago

BTC-USD

GC=F
What the CHIPS Act, grants could look like under new Trump admin.

As the Biden administration attempts to hand out and adjust CHIPS & Science Act funding to chipmakers, what is the commentary from President-elect Donald Trump and his incoming administration around boosting domestic semiconductor production? Notably, the US is reportedly cutting Intel's (INTC) $8.5 billion chipmaking grant to below $8 billion as officials try to balance that with the $3.5 billion grant the company was awarded from the Pentagon. "It's worth remembering that it was the first Trump administration that devised the concept of trying to incentivize firms to build more in the US, the CHIPS act was first discussed in Congress under the Trump administration, the first investment of TSMC (TSM) — the Taiwanese company in Arizona — was announced under the first Trump administration," Tufts University professor of International History Christopher Miller tells Julie Hyman and Josh Lipton. "And so I wouldn't be surprised to see some small changes to the program. Specific grants might be amended, but the basic framework of trying to use financial incentives to get more chips made domestically, that's an idea the first Trump administration more or less came up with." The Chip War: The Fight for the World's Most Critical Technology author weighs in on the future of tariff policies and import-export controls, especially those targeting China, under a second Trump administration To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 16 hours ago

NVDA

AAPL
Bitcoin is taking a breather. There's more upside ahead: Analyst

Bitcoin has yet to hit $100,000. The cryptocurrency traded lower Monday afternoon after prices rose more than 40% over the last month. Traders shouldn't panic, though, Explosive Options technical analyst Bob Lang tells Yahoo Finance. Lang describes a bit of a pullback as "constructive" for bitcoin (BTC-USD) prices, adding that it could represent an opportunity for prospective buyers to get in. "There's a lot of people on the sidelines who are waiting for an opportunity to get into bitcoin and other cryptocurrencies. And this next pullback, whatever the size may be, it could be 5%, 10%, could be that one opportunity for people to get in." He also says that the momentum from this rally is "incredible" and that bitcoin prices "could make a run much further than most people expect." Watch the video above to hear what Lang has to say about the growing bitcoin options market. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Stephanie Mikulich.

Yahoo Finance Video 17 hours ago

BTC-USD
Rivian gains on reported conditional settlement with Tesla

Rivian (RIVN) stock surges after reports from Bloomberg said Tesla (TSLA) has reached a "conditional" settlement with its electric vehicle (EV) competitor. Tesla accused Rivian of poaching employees to access proprietary information about its EV tech. Market Domination Hosts Julie Hyman and Josh Lipton break down the headline. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan.

Yahoo Finance Video 17 hours ago

RIVN

TSLA
US to reduce Intel's CHIPS grant to below $8 billion: NYT

The US is reducing its CHIPS & Science Act grant allotted to Intel (INTC) to below $8 billion, down from the originally proposed $8.5 billion, as officials account for the semiconductor giant's other $3 billion-plus grant for making chips for the Pentagon. The Morning Brief's Seana Smith and Brad Smith break down the New York Times report while Intel's stock moves to the upside this morning. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 23 hours ago

INTC
Dow Jones Futures Fall On Trump Tariff Threat; Nvidia Stock Hangs At Key Level

Dow Jones futures dropped Tuesday on President-elect Donald Trump's tariff threat on China, Canada and Mexico. Nvidia is at a key level.

Investor's Business Daily 6 minutes ago

BBY

ANF
Analog Devices Q4 Earnings: Beats Estimates, Automotive Rebound, Cautiously Optimistic Outlook & More

Analog Devices, Inc (NASDAQ:ADI) stock traded higher Tuesday after the company reported fiscal fourth-quarter results. The company’s revenue declined 10% year-on-year to $2.44 billion, beating the analyst consensus estimate of $2.40 billion. Adjusted EPS of $1.67 beat the analyst consensus estimate of $1.64. Also Read: Taiwan Semi’s Growth Fuels US Rise To Second In Chipmaking: Report Analog Devices’ Industrial revenue declined by 21% Y/Y to $1.07 billion. Automotive revenue decreased 2% Y/Y to

Benzinga 8 minutes ago

ADI
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details

On Tuesday, Roche Holdings AG (OTC:RHHBY) agreed to acquire Poseida Therapeutics, Inc. (NASDAQ:PSTX) for an equity value of approximately $1.5 billion on a fully diluted basis. The deal consideration includes $9.00 per share in cash plus a non-tradeable CVR to receive certain contingent payments of up to an aggregate of $4.00 per share in cash upon achievement of specific milestones. Also Read: Roche’s Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings’ $16.5B Catale

Benzinga 17 minutes ago

ROG.SW

PSTX
Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta

Shares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics.

Investor's Business Daily 18 minutes ago

ARWR

SRPT
Best Buy is in Concerning Performance Trend

Best Buy Reports Mixed Q4 FY24 Results, Increases Dividend Despite Earnings Miss

GuruFocus.com 27 minutes ago

BBY
Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test

Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's Zepbound.

Investor's Business Daily 30 minutes ago

AMGN

LLY
Zoom Communications slumps as lackluster growth worries investors

Zoom Communications shares tumbled nearly 11% before the bell on Tuesday, as its forecast for low single-digit annual revenue growth disappointed investors after a recent rally. Stiff competition from rival video conferencing services including Microsoft Teams has pressured Zoom, even as it expands its offerings with products such as phone systems and artificial intelligence assistants to boost demand. Zoom, which rose to prominence during the pandemic, raised its expectations for fiscal year 2025 adjusted profit and revenue on Monday.

Reuters 32 minutes ago

ZM
J.M. Smucker Q2: Earnings Beat, 17% Sales Surge, FY25 EPS Outlook Boost & More

The J.M. Smucker Company (NYSE:SJM) shares are trading higher on Tuesday. The company reported second-quarter adjusted earnings per share of $2.76, beating the street view of $2.51. Quarterly sales of $2.271 billion (+17%) beat the analyst consensus estimate of $2.264 billion. The increase in comparable net sales reflects a 2 percentage point increase from volume/mix, primarily driven by increases for the Uncrustables, Meow Mix, Café Bustelo, and Jif brands. U.S. Retail Coffee net sales rose 3%

Benzinga 32 minutes ago

SJM
These Stocks Are Moving the Most Today: Rivian, Ford, Amgen, Zoom, Semtech, Analog Devices, Dick’s, Kohl’s, and More

Rivian receives a loan of up to $6.6 billion from the U.S. government to boost electric-vehicle production, while shares of Ford and General Motors fall after President-elect Donald Trump announces his tariff plans.

Barrons.com 45 minutes ago

CRWD

RIVN
Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

On Tuesday, Amgen Inc (NASDAQ:AMGN) stock fell during the premarket session after the company released long-anticipated data from the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133) in obese patients. The company said that MariTide demonstrated up to ~20% average weight loss at one year (52 weeks) without a weight loss plateau, indicating the potential for further weight loss beyond 52 weeks. Amgen’s stock dropped as the results seemed to fall short of Wall Street’s high ex

Benzinga 47 minutes ago

AMGN
Analog Devices beats Q4 targets on chip demand recovery from auto industry

Chipmaker Analog Devices topped analysts' estimates for fourth-quarter revenue and profit on Tuesday, helped by strong demand for its semiconductors used in consumer electronics and a recovery in orders from the auto industry. Shares of the Wilmington, Massachusetts-based company rose 7% in premarket trading. Demand for consumer electronics has recovered from a post-pandemic lull, while trends in the auto segment are also improving.

Reuters 51 minutes ago

ADI
Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.

Amgen stock was dropping in premarket trading, despite positive data from a Phase 2 study for its experimental weight-loss drug, MariTide. The pharmaceutical company said in a statement that after 52 weeks, there was an average 20% weight loss “in people living with obesity or overweight without Type 2 diabetes.” It said the numbers didn’t plateau, which indicated MariTide’s potential for further weight loss beyond 52 weeks.

Barrons.com 52 minutes ago

AMGN

LLY
Kohl's Stock Crashes 17% as Weak Performance and CEO Shake-Up Rock Investor Confidence

Disappointing Q3 results, slashed forecasts, and a leadership overhaul spark fears for Kohl's future

GuruFocus.com 54 minutes ago

KSS
Kohl's Q3 Misses The Mark: Weak Sales And CEO Shake-Up Send Shares Down

Kohl’s Corp (NYSE:KSS) shares are trading lower after the company reported third-quarter earnings. The company reported a net sales decline of 8.8% year-over-year (Y/Y) to $3.507 billion, missing the consensus of $3.638 billion. Comparable sales for the quarter decreased 9.3%. Total revenue stood at $3.710 billion. Gross margin for the quarter expanded by 20 basis points to 39.1%. Operating income for the quarter was $98 million versus $157 million last year. The operating margin contracted 120

Benzinga 56 minutes ago

KSS

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Trending Tickers

Related News

New Trump tariffs, Fed minutes, Intel CHIPS grant: 3 Things

Should the US Treasury be buying bitcoin?

What the CHIPS Act, grants could look like under new Trump admin.

Bitcoin is taking a breather. There's more upside ahead: Analyst

Rivian gains on reported conditional settlement with Tesla

US to reduce Intel's CHIPS grant to below $8 billion: NYT

Dow Jones Futures Fall On Trump Tariff Threat; Nvidia Stock Hangs At Key Level

Analog Devices Q4 Earnings: Beats Estimates, Automotive Rebound, Cautiously Optimistic Outlook & More

Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details

Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta

Best Buy is in Concerning Performance Trend

Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test

Zoom Communications slumps as lackluster growth worries investors

J.M. Smucker Q2: Earnings Beat, 17% Sales Surge, FY25 EPS Outlook Boost & More

These Stocks Are Moving the Most Today: Rivian, Ford, Amgen, Zoom, Semtech, Analog Devices, Dick’s, Kohl’s, and More

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

Analog Devices beats Q4 targets on chip demand recovery from auto industry

Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.

Kohl's Stock Crashes 17% as Weak Performance and CEO Shake-Up Rock Investor Confidence

Kohl's Q3 Misses The Mark: Weak Sales And CEO Shake-Up Send Shares Down